Payload Information
General Information of This Payload
| Payload ID | PAY0GHAAL |
|||||
|---|---|---|---|---|---|---|
| Name | Compound I-5c |
|||||
| Synonyms |
Compound I-5c
Click to Show/Hide
|
|||||
| Structure |
|
|||||
| Formula | C30H36N8O11P2S2 |
|||||
| Isosmiles | CNCC1=C(CC(NC2=NC3=C(N=CN3[C@H]4[C@H](O5)C(O)[C@H](O4)CO[P@@](S)(O[C@@H]6CC(OC7=NC=NC=C7)C[C@H]6CO[P@]5(S)=O)=O)C(N2)=O)=O)C=CC=C1 |
|||||
| InChI |
InChI=1S/C30H36N8O11P2S2/c1-31-11-17-5-3-2-4-16(17)9-22(39)35-30-36-27-24(28(41)37-30)34-15-38(27)29-26-25(40)21(47-29)13-45-50(42,52)48-20-10-19(46-23-6-7-32-14-33-23)8-18(20)12-44-51(43,53)49-26/h2-7,14-15,18-21,25-26,29,31,40H,8-13H2,1H3,(H,42,52)(H,43,53)(H2,35,36,37,39,41)/t18-,19?,20+,21+,25?,26+,29+,50+,51+/m0/s1
|
|||||
| InChIKey |
VWMJHFIAKRBWMK-JMQMGDKPSA-N
|
|||||
| Pharmaceutical Properties | Molecule Weight |
810.745 |
Polar area |
240.23 |
||
Complexity |
2022.680053 |
xlogp Value |
2.8191 |
|||
Heavy Count |
53 |
Rot Bonds |
8 |
|||
Hbond acc |
17 |
Hbond Donor |
6 |
|||
Each Antibody-drug Conjugate Related to This Payload
Full Information of The Activity Data of The ADC(s) Related to This Payload
CN116916962A-ADC-B14 [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal Effective Concentration (EC50) |
0.53 nM
|
High hCCR2 expression (hCCR2+++) | ||
| Method Description |
THP 1, 15,000cells/254uL per welld were plated at set in 384 well flat plate, in the appropriate growth media. The cell plates were dosed with 5uL of the hCCR2 targeting-ADC samples and then incubated at 37°C for 20 hours. At the end of the incubation 10uL/well of the QUANTJ-LucTM (InvivoGenftrep-qlc1) were added and luminescence was measured immediately using the LeadSeeker.
Click to Show/Hide
|
||||
| In Vitro Model | Acute monoblastic/monocytic leukemia, Childhood acute monocytic leukemia | THP1 cells | CVCL_0006 | ||
CN116916962A-ADC-B16 [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal Effective Concentration (EC50) |
2.46 nM
|
High hCCR2 expression (hCCR2+++) | ||
| Method Description |
THP 1, 15,000cells/254uL per welld were plated at set in 384 well flat plate, in the appropriate growth media. The cell plates were dosed with 5uL of the hCCR2 targeting-ADC samples and then incubated at 37°C for 20 hours. At the end of the incubation 10uL/well of the QUANTJ-LucTM (InvivoGenftrep-qlc1) were added and luminescence was measured immediately using the LeadSeeker.
Click to Show/Hide
|
||||
| In Vitro Model | Acute monoblastic/monocytic leukemia, Childhood acute monocytic leukemia | THP1 cells | CVCL_0006 | ||
CN116916962A-ADC-B19 [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal Effective Concentration (EC50) |
3.09 nM
|
High hCCR2 expression (hCCR2+++) | ||
| Method Description |
THP 1, 15,000cells/254uL per welld were plated at set in 384 well flat plate, in the appropriate growth media. The cell plates were dosed with 5uL of the hCCR2 targeting-ADC samples and then incubated at 37°C for 20 hours. At the end of the incubation 10uL/well of the QUANTJ-LucTM (InvivoGenftrep-qlc1) were added and luminescence was measured immediately using the LeadSeeker.
Click to Show/Hide
|
||||
| In Vitro Model | Acute monoblastic/monocytic leukemia, Childhood acute monocytic leukemia | THP1 cells | CVCL_0006 | ||
CN116916962A-ADC-B18 [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal Effective Concentration (EC50) |
48.2 nM
|
High hCCR2 expression (hCCR2+++) | ||
| Method Description |
THP 1, 15,000cells/254uL per welld were plated at set in 384 well flat plate, in the appropriate growth media. The cell plates were dosed with 5uL of the hCCR2 targeting-ADC samples and then incubated at 37°C for 20 hours. At the end of the incubation 10uL/well of the QUANTJ-LucTM (InvivoGenftrep-qlc1) were added and luminescence was measured immediately using the LeadSeeker.
Click to Show/Hide
|
||||
| In Vitro Model | Acute monoblastic/monocytic leukemia, Childhood acute monocytic leukemia | THP1 cells | CVCL_0006 | ||
CN116916962A-ADC-B15 [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal Effective Concentration (EC50) |
302 nM
|
High hCCR2 expression (hCCR2+++) | ||
| Method Description |
THP 1, 15,000cells/254uL per welld were plated at set in 384 well flat plate, in the appropriate growth media. The cell plates were dosed with 5uL of the hCCR2 targeting-ADC samples and then incubated at 37°C for 20 hours. At the end of the incubation 10uL/well of the QUANTJ-LucTM (InvivoGenftrep-qlc1) were added and luminescence was measured immediately using the LeadSeeker.
Click to Show/Hide
|
||||
| In Vitro Model | Acute monoblastic/monocytic leukemia, Childhood acute monocytic leukemia | THP1 cells | CVCL_0006 | ||